-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Feb 06, 16:01Prev. Close
2443.10
Open Price
2413.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:58Prev. Close
2444.60
Open Price
2444.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 646.99 | 658.82 | 523.79 | 465.35 | 573.63 | |
| Net CashFlow From Operating Activities | 490.97 | 411.18 | 474.77 | 232.28 | 138.27 | |
| Net Cash Used In Investing Activities | -63.10 | -154.44 | -107.01 | 303.08 | 499.09 | |
| Net Cash Used From Financing Activities | -427.62 | -358.36 | -306.63 | -510.76 | -638.33 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.25 | -101.62 | 61.12 | 24.59 | -0.98 | |
| Cash And Cash Equivalents Begin of Year | 97.78 | 199.40 | 138.27 | 113.68 | 114.66 | |
| Cash And Cash Equivalents End Of Year | 98.03 | 97.78 | 199.40 | 138.27 | 113.68 |
12.11.2025
GlaxoSmithKline Standalone September 2025 Net Sales at Rs 973.63 crore, down 2.64% Y-o-Y
07.11.2025
GlaxoSmithKline Consolidated September 2025 Net Sales at Rs 979.94 crore, down 3.05% Y-o-Y
12.08.2025
GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y
01.08.2025
GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y
